Testing for Doxorubicin Cardiotoxicity

B. Hoefling, J. Zaehringer, H. D. Bolte, Michael R. Bristow, John P. Wexler, M. Donald Blaufox, Leonard M. Freeman, Jonathan Alexander, Harvey J. Berger, Barry L. Zaret, I. Craig Henderson, Emil Frei

Research output: Contribution to journalLetter

3 Citations (Scopus)

Abstract

To the Editor: The February 8 issue of the Journal contained an article by Alexander et al.1 and an editorial by Henderson and Frei2 on the cardiotoxicity of doxorubicin. Both the article and the editorial concluded that sensitive measurements of myocardial function could be used as criteria for discontinuation of doxorubicin treatment. We do agree that even low doses of doxorubicin can produce changes in myocardial function, as shown previously by Friedman et al.,3 Stein et al.4 and our own unpublished results. At doses of about 200 mg per square meter, we found changes in myocardial function in five of.

Original languageEnglish (US)
Pages (from-to)1392-1394
Number of pages3
JournalNew England Journal of Medicine
Volume300
Issue number24
DOIs
StatePublished - Jun 14 1979

Fingerprint

Doxorubicin
Cardiotoxicity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hoefling, B., Zaehringer, J., Bolte, H. D., Bristow, M. R., Wexler, J. P., Blaufox, M. D., ... Frei, E. (1979). Testing for Doxorubicin Cardiotoxicity. New England Journal of Medicine, 300(24), 1392-1394. https://doi.org/10.1056/NEJM197906143002412

Testing for Doxorubicin Cardiotoxicity. / Hoefling, B.; Zaehringer, J.; Bolte, H. D.; Bristow, Michael R.; Wexler, John P.; Blaufox, M. Donald; Freeman, Leonard M.; Alexander, Jonathan; Berger, Harvey J.; Zaret, Barry L.; Henderson, I. Craig; Frei, Emil.

In: New England Journal of Medicine, Vol. 300, No. 24, 14.06.1979, p. 1392-1394.

Research output: Contribution to journalLetter

Hoefling, B, Zaehringer, J, Bolte, HD, Bristow, MR, Wexler, JP, Blaufox, MD, Freeman, LM, Alexander, J, Berger, HJ, Zaret, BL, Henderson, IC & Frei, E 1979, 'Testing for Doxorubicin Cardiotoxicity', New England Journal of Medicine, vol. 300, no. 24, pp. 1392-1394. https://doi.org/10.1056/NEJM197906143002412
Hoefling B, Zaehringer J, Bolte HD, Bristow MR, Wexler JP, Blaufox MD et al. Testing for Doxorubicin Cardiotoxicity. New England Journal of Medicine. 1979 Jun 14;300(24):1392-1394. https://doi.org/10.1056/NEJM197906143002412
Hoefling, B. ; Zaehringer, J. ; Bolte, H. D. ; Bristow, Michael R. ; Wexler, John P. ; Blaufox, M. Donald ; Freeman, Leonard M. ; Alexander, Jonathan ; Berger, Harvey J. ; Zaret, Barry L. ; Henderson, I. Craig ; Frei, Emil. / Testing for Doxorubicin Cardiotoxicity. In: New England Journal of Medicine. 1979 ; Vol. 300, No. 24. pp. 1392-1394.
@article{71adce53cfd04923b40d3339bfe51882,
title = "Testing for Doxorubicin Cardiotoxicity",
abstract = "To the Editor: The February 8 issue of the Journal contained an article by Alexander et al.1 and an editorial by Henderson and Frei2 on the cardiotoxicity of doxorubicin. Both the article and the editorial concluded that sensitive measurements of myocardial function could be used as criteria for discontinuation of doxorubicin treatment. We do agree that even low doses of doxorubicin can produce changes in myocardial function, as shown previously by Friedman et al.,3 Stein et al.4 and our own unpublished results. At doses of about 200 mg per square meter, we found changes in myocardial function in five of.",
author = "B. Hoefling and J. Zaehringer and Bolte, {H. D.} and Bristow, {Michael R.} and Wexler, {John P.} and Blaufox, {M. Donald} and Freeman, {Leonard M.} and Jonathan Alexander and Berger, {Harvey J.} and Zaret, {Barry L.} and Henderson, {I. Craig} and Emil Frei",
year = "1979",
month = "6",
day = "14",
doi = "10.1056/NEJM197906143002412",
language = "English (US)",
volume = "300",
pages = "1392--1394",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "24",

}

TY - JOUR

T1 - Testing for Doxorubicin Cardiotoxicity

AU - Hoefling, B.

AU - Zaehringer, J.

AU - Bolte, H. D.

AU - Bristow, Michael R.

AU - Wexler, John P.

AU - Blaufox, M. Donald

AU - Freeman, Leonard M.

AU - Alexander, Jonathan

AU - Berger, Harvey J.

AU - Zaret, Barry L.

AU - Henderson, I. Craig

AU - Frei, Emil

PY - 1979/6/14

Y1 - 1979/6/14

N2 - To the Editor: The February 8 issue of the Journal contained an article by Alexander et al.1 and an editorial by Henderson and Frei2 on the cardiotoxicity of doxorubicin. Both the article and the editorial concluded that sensitive measurements of myocardial function could be used as criteria for discontinuation of doxorubicin treatment. We do agree that even low doses of doxorubicin can produce changes in myocardial function, as shown previously by Friedman et al.,3 Stein et al.4 and our own unpublished results. At doses of about 200 mg per square meter, we found changes in myocardial function in five of.

AB - To the Editor: The February 8 issue of the Journal contained an article by Alexander et al.1 and an editorial by Henderson and Frei2 on the cardiotoxicity of doxorubicin. Both the article and the editorial concluded that sensitive measurements of myocardial function could be used as criteria for discontinuation of doxorubicin treatment. We do agree that even low doses of doxorubicin can produce changes in myocardial function, as shown previously by Friedman et al.,3 Stein et al.4 and our own unpublished results. At doses of about 200 mg per square meter, we found changes in myocardial function in five of.

UR - http://www.scopus.com/inward/record.url?scp=0018396767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018396767&partnerID=8YFLogxK

U2 - 10.1056/NEJM197906143002412

DO - 10.1056/NEJM197906143002412

M3 - Letter

VL - 300

SP - 1392

EP - 1394

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 24

ER -